NAU publications by CHER
Faculty & staff publications
NAU faculty and staff have the opportunity to publish their findings and knowledge as authors. CHER has many researchers that have been cited multiple times in major publications for their great work. The Center for Health Equity Research has accumulated all faculty publications into one, easy to navigate database.
Please type in a key word or author LAST name to search
Abdul-Chani, Monical; Moreno, Christopher P; Reeder, Julia A; Zuckerman, Katherine; Lindly, Olivia Perceived community disability stigma in multicultural, low-income populations: Measure development and validation Journal Article Research in Developmental Disabilities, 115 , 2021. @article{Abdul-Chani2021, title = {Perceived community disability stigma in multicultural, low-income populations: Measure development and validation}, author = {Monical Abdul-Chani and Christopher P Moreno and Julia A Reeder and Katherine Zuckerman and Olivia Lindly}, url = {https://doi.org/10.1016/j.ridd.2021.103997}, doi = {10.1016/j.ridd.2021.103997}, year = {2021}, date = {2021-05-29}, journal = {Research in Developmental Disabilities}, volume = {115}, abstract = {Stigma and knowledge about disabilities differ across groups, impacting care. No validated measures of perceived community disability stigma exist for families in multicultural communities, at risk for disparities.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Stigma and knowledge about disabilities differ across groups, impacting care. No validated measures of perceived community disability stigma exist for families in multicultural communities, at risk for disparities. |
Martinez-Hume, Anna C; Baker, Allison M; Bell, Hannah S; Montemayor, Isabel; Elwell, Kristan; Hunt, Linda M "They Treat you a Different Way:" Public Insurance, Stigma, and the Challenge to Quality Health Care Journal Article Culture, Medicine, and Psychiatry, 41 (1), pp. 161-180, 2017. @article{Martinez-Hume2017, title = {"They Treat you a Different Way:" Public Insurance, Stigma, and the Challenge to Quality Health Care}, author = {Anna C Martinez-Hume and Allison M Baker and Hannah S Bell and Isabel Montemayor and Kristan Elwell and Linda M Hunt}, url = {https://www.ncbi.nlm.nih.gov/pubmed/28025774}, year = {2017}, date = {2017-03-01}, journal = {Culture, Medicine, and Psychiatry}, volume = {41}, number = {1}, pages = {161-180}, abstract = {Under the Affordable Care Act, Medicaid Expansion programs are extending Medicaid eligibility and increasing access to care. However, stigma associated with public insurance coverage may importantly affect the nature and content of the health care beneficiaries receive. In this paper, we examine the health care stigma experiences described by a group of low-income public insurance beneficiaries. They perceive stigma as manifest in poor quality care and negative interpersonal interactions in the health care setting. Using an intersectional approach, we found that the stigma of public insurance was compounded with other sources of stigma including socioeconomic status, race, gender, and illness status. Experiences of stigma had important implications for how subjects evaluated the quality of care, their decisions impacting continuity of care, and their reported ability to access health care. We argue that stigma challenges the quality of care provided under public insurance and is thus a public health issue that should be addressed in Medicaid policy.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Under the Affordable Care Act, Medicaid Expansion programs are extending Medicaid eligibility and increasing access to care. However, stigma associated with public insurance coverage may importantly affect the nature and content of the health care beneficiaries receive. In this paper, we examine the health care stigma experiences described by a group of low-income public insurance beneficiaries. They perceive stigma as manifest in poor quality care and negative interpersonal interactions in the health care setting. Using an intersectional approach, we found that the stigma of public insurance was compounded with other sources of stigma including socioeconomic status, race, gender, and illness status. Experiences of stigma had important implications for how subjects evaluated the quality of care, their decisions impacting continuity of care, and their reported ability to access health care. We argue that stigma challenges the quality of care provided under public insurance and is thus a public health issue that should be addressed in Medicaid policy. |
Eaves, Emery R "Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain Journal Article Social Science and Medicine, 146 , pp. 147-154, 2015. @article{Eaves2015, title = {"Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain}, author = {Emery R Eaves}, url = {https://www.ncbi.nlm.nih.gov/pubmed/26517291}, doi = {10.1016/j.socscimed.2015.10.033}, year = {2015}, date = {2015-12-01}, journal = {Social Science and Medicine}, volume = {146}, pages = {147-154}, abstract = {Direct-to-consumer marketing has sparked ongoing debate concerning whether ads empower consumers to be agents of their own care or shift greater control to the pharmaceutical industry. Ads for over-the-counter (OTC) medications in particular portend to offer simple, harmless solutions for meeting the demands of social life. Rather than join the longstanding debate between consumer agency and social control in pharmaceutical advertising, I approach self-medication with over-the-counter (OTC) analgesics using Harm Reduction as a framework. From this perspective, consumption of OTC analgesics by chronic pain sufferers is a means of seeking some level of relief while also avoiding the stigma associated with prescription pain medication. Qualitative methods are used to analyze data from two sources: (1) semi-structured qualitative interviews with 95 participants in a trial examining the effectiveness of Traditional Chinese Medicine for Temporomandibular Disorders (TMD) from 2006 to 2011 in Tucson, AZ and Portland, OR; and (2) print, online, and television advertisements for three major brands of OTC pain medication. Participants described their use of OTC medications as minimal, responsible, and justified by the severity of their pain. OTC medication advertising, while ostensibly ambiguous and targeting all forms of pain, effectively lends support to the consumption of these medications as part of the self-projects of chronic pain sufferers, allowing them to reconcile conflicting demands for pain relief while being stoic and maintaining a positive moral identity. Describing OTC medication as "just over-the-counter" or "not real pain medication," sufferers engage in ideological harm reduction, distinguishing themselves from "those people who like taking pain medication" while still seeking relief. Justifying one's use of OTC medication as minimal and "normal," regardless of intake, avoids association with the addictive potential of prescription pain medications and aligns the identity of the chronic pain sufferer with a culturally sanctioned identity as stoic bearer of pain.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Direct-to-consumer marketing has sparked ongoing debate concerning whether ads empower consumers to be agents of their own care or shift greater control to the pharmaceutical industry. Ads for over-the-counter (OTC) medications in particular portend to offer simple, harmless solutions for meeting the demands of social life. Rather than join the longstanding debate between consumer agency and social control in pharmaceutical advertising, I approach self-medication with over-the-counter (OTC) analgesics using Harm Reduction as a framework. From this perspective, consumption of OTC analgesics by chronic pain sufferers is a means of seeking some level of relief while also avoiding the stigma associated with prescription pain medication. Qualitative methods are used to analyze data from two sources: (1) semi-structured qualitative interviews with 95 participants in a trial examining the effectiveness of Traditional Chinese Medicine for Temporomandibular Disorders (TMD) from 2006 to 2011 in Tucson, AZ and Portland, OR; and (2) print, online, and television advertisements for three major brands of OTC pain medication. Participants described their use of OTC medications as minimal, responsible, and justified by the severity of their pain. OTC medication advertising, while ostensibly ambiguous and targeting all forms of pain, effectively lends support to the consumption of these medications as part of the self-projects of chronic pain sufferers, allowing them to reconcile conflicting demands for pain relief while being stoic and maintaining a positive moral identity. Describing OTC medication as "just over-the-counter" or "not real pain medication," sufferers engage in ideological harm reduction, distinguishing themselves from "those people who like taking pain medication" while still seeking relief. Justifying one's use of OTC medication as minimal and "normal," regardless of intake, avoids association with the addictive potential of prescription pain medications and aligns the identity of the chronic pain sufferer with a culturally sanctioned identity as stoic bearer of pain. |
2021 |
Abdul-Chani, Monical; Moreno, Christopher P; Reeder, Julia A; Zuckerman, Katherine; Lindly, Olivia Perceived community disability stigma in multicultural, low-income populations: Measure development and validation Journal Article Research in Developmental Disabilities, 115 , 2021. @article{Abdul-Chani2021, title = {Perceived community disability stigma in multicultural, low-income populations: Measure development and validation}, author = {Monical Abdul-Chani and Christopher P Moreno and Julia A Reeder and Katherine Zuckerman and Olivia Lindly}, url = {https://doi.org/10.1016/j.ridd.2021.103997}, doi = {10.1016/j.ridd.2021.103997}, year = {2021}, date = {2021-05-29}, journal = {Research in Developmental Disabilities}, volume = {115}, abstract = {Stigma and knowledge about disabilities differ across groups, impacting care. No validated measures of perceived community disability stigma exist for families in multicultural communities, at risk for disparities.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Stigma and knowledge about disabilities differ across groups, impacting care. No validated measures of perceived community disability stigma exist for families in multicultural communities, at risk for disparities. |
2017 |
Martinez-Hume, Anna C; Baker, Allison M; Bell, Hannah S; Montemayor, Isabel; Elwell, Kristan; Hunt, Linda M "They Treat you a Different Way:" Public Insurance, Stigma, and the Challenge to Quality Health Care Journal Article Culture, Medicine, and Psychiatry, 41 (1), pp. 161-180, 2017. @article{Martinez-Hume2017, title = {"They Treat you a Different Way:" Public Insurance, Stigma, and the Challenge to Quality Health Care}, author = {Anna C Martinez-Hume and Allison M Baker and Hannah S Bell and Isabel Montemayor and Kristan Elwell and Linda M Hunt}, url = {https://www.ncbi.nlm.nih.gov/pubmed/28025774}, year = {2017}, date = {2017-03-01}, journal = {Culture, Medicine, and Psychiatry}, volume = {41}, number = {1}, pages = {161-180}, abstract = {Under the Affordable Care Act, Medicaid Expansion programs are extending Medicaid eligibility and increasing access to care. However, stigma associated with public insurance coverage may importantly affect the nature and content of the health care beneficiaries receive. In this paper, we examine the health care stigma experiences described by a group of low-income public insurance beneficiaries. They perceive stigma as manifest in poor quality care and negative interpersonal interactions in the health care setting. Using an intersectional approach, we found that the stigma of public insurance was compounded with other sources of stigma including socioeconomic status, race, gender, and illness status. Experiences of stigma had important implications for how subjects evaluated the quality of care, their decisions impacting continuity of care, and their reported ability to access health care. We argue that stigma challenges the quality of care provided under public insurance and is thus a public health issue that should be addressed in Medicaid policy.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Under the Affordable Care Act, Medicaid Expansion programs are extending Medicaid eligibility and increasing access to care. However, stigma associated with public insurance coverage may importantly affect the nature and content of the health care beneficiaries receive. In this paper, we examine the health care stigma experiences described by a group of low-income public insurance beneficiaries. They perceive stigma as manifest in poor quality care and negative interpersonal interactions in the health care setting. Using an intersectional approach, we found that the stigma of public insurance was compounded with other sources of stigma including socioeconomic status, race, gender, and illness status. Experiences of stigma had important implications for how subjects evaluated the quality of care, their decisions impacting continuity of care, and their reported ability to access health care. We argue that stigma challenges the quality of care provided under public insurance and is thus a public health issue that should be addressed in Medicaid policy. |
2015 |
Eaves, Emery R "Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain Journal Article Social Science and Medicine, 146 , pp. 147-154, 2015. @article{Eaves2015, title = {"Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain}, author = {Emery R Eaves}, url = {https://www.ncbi.nlm.nih.gov/pubmed/26517291}, doi = {10.1016/j.socscimed.2015.10.033}, year = {2015}, date = {2015-12-01}, journal = {Social Science and Medicine}, volume = {146}, pages = {147-154}, abstract = {Direct-to-consumer marketing has sparked ongoing debate concerning whether ads empower consumers to be agents of their own care or shift greater control to the pharmaceutical industry. Ads for over-the-counter (OTC) medications in particular portend to offer simple, harmless solutions for meeting the demands of social life. Rather than join the longstanding debate between consumer agency and social control in pharmaceutical advertising, I approach self-medication with over-the-counter (OTC) analgesics using Harm Reduction as a framework. From this perspective, consumption of OTC analgesics by chronic pain sufferers is a means of seeking some level of relief while also avoiding the stigma associated with prescription pain medication. Qualitative methods are used to analyze data from two sources: (1) semi-structured qualitative interviews with 95 participants in a trial examining the effectiveness of Traditional Chinese Medicine for Temporomandibular Disorders (TMD) from 2006 to 2011 in Tucson, AZ and Portland, OR; and (2) print, online, and television advertisements for three major brands of OTC pain medication. Participants described their use of OTC medications as minimal, responsible, and justified by the severity of their pain. OTC medication advertising, while ostensibly ambiguous and targeting all forms of pain, effectively lends support to the consumption of these medications as part of the self-projects of chronic pain sufferers, allowing them to reconcile conflicting demands for pain relief while being stoic and maintaining a positive moral identity. Describing OTC medication as "just over-the-counter" or "not real pain medication," sufferers engage in ideological harm reduction, distinguishing themselves from "those people who like taking pain medication" while still seeking relief. Justifying one's use of OTC medication as minimal and "normal," regardless of intake, avoids association with the addictive potential of prescription pain medications and aligns the identity of the chronic pain sufferer with a culturally sanctioned identity as stoic bearer of pain.}, keywords = {}, pubstate = {published}, tppubtype = {article} } Direct-to-consumer marketing has sparked ongoing debate concerning whether ads empower consumers to be agents of their own care or shift greater control to the pharmaceutical industry. Ads for over-the-counter (OTC) medications in particular portend to offer simple, harmless solutions for meeting the demands of social life. Rather than join the longstanding debate between consumer agency and social control in pharmaceutical advertising, I approach self-medication with over-the-counter (OTC) analgesics using Harm Reduction as a framework. From this perspective, consumption of OTC analgesics by chronic pain sufferers is a means of seeking some level of relief while also avoiding the stigma associated with prescription pain medication. Qualitative methods are used to analyze data from two sources: (1) semi-structured qualitative interviews with 95 participants in a trial examining the effectiveness of Traditional Chinese Medicine for Temporomandibular Disorders (TMD) from 2006 to 2011 in Tucson, AZ and Portland, OR; and (2) print, online, and television advertisements for three major brands of OTC pain medication. Participants described their use of OTC medications as minimal, responsible, and justified by the severity of their pain. OTC medication advertising, while ostensibly ambiguous and targeting all forms of pain, effectively lends support to the consumption of these medications as part of the self-projects of chronic pain sufferers, allowing them to reconcile conflicting demands for pain relief while being stoic and maintaining a positive moral identity. Describing OTC medication as "just over-the-counter" or "not real pain medication," sufferers engage in ideological harm reduction, distinguishing themselves from "those people who like taking pain medication" while still seeking relief. Justifying one's use of OTC medication as minimal and "normal," regardless of intake, avoids association with the addictive potential of prescription pain medications and aligns the identity of the chronic pain sufferer with a culturally sanctioned identity as stoic bearer of pain. |